Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: Application of the Scleroderma Clinical Trials Consortium Damage Index in patients with juvenile systemic sclerosis

Fig. 1

Correlations between juvenile systemic sclerosis severity score (J4S) and Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI) in patients with juvenile systemic sclerosis (jSSc). A Correlations between baseline J4S of jSSc patients and the SCTC-DI at follow-up; B Correlations between baseline J4S and follow-up SCTC-DI in patients with diffuse cutaneous jSSc; C Correlations between baseline J4S and follow-up SCTC-DI in patients with limited cutaneous jSSc

Back to article page